MDM2 and MDMX function together as the p53 E3 ligase
MDM2 and MDMX function together as the p53 E3 ligase
批准号:
8898020
负责人:
ZHI-MIN YUAN
金额:
$26.68万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-15 至 2017-07-31
关键词:
AdultAffectAnimal ModelBindingBiochemicalBiologicalBiological AssayBreedingCellsCellular Stress ResponseComplexDNA DamageDataEmbryoHumanIn VitroInvestigationKnock-in MouseKnock-outLibrariesLightMDM2 geneMediatingModificationMolecularMusMutant Strains MiceOncogene ActivationPathway interactionsPhysiologicalPlayPoint MutationPositioning AttributePost-Translational Protein ProcessingProteinsRNA InterferenceRegulationRoleSignal TransductionStressTestingTherapeuticUbiquitinUbiquitinationWorkbasein vivointerestmdm2 proteinmouse modelmutantnew therapeutic targetnovelresponseubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): As a master regulator of cellular stress response, p53 plays an important role in cell fate decisions. The activity of p53 therefore must be precisely regulated. Among numerous proteins involved in p53 control, MDM2 and MDMX are the key players, as evidenced by the fact that knockout of either mdm2 or mdmx in mice resulted in p53-dependent lethality. However, little is known about why both MDM2 and MDMX are required in p53 control, and the molecular mechanisms underlying MDM2 and MDMX-mediated p53 regulation remain not fully defined. Others and we have shown that MDM2 and MDMX form a heterocomplex and, more importantly, that they depend on each other in p53 regulation. Structural and biochemical evidence further indicate that formation of the MDM2/MDMX heterocomplex is favored. Our hypothesis is that the heterocomplex represents the physiological form of MDM2 and MDMX in p53 control. The proposed studies will use mouse models to directly test this hypothesis. We will also fully characterize the MDM2/MDMX heterocomplex in p53 ubiquitination and in regulation of the p53 response to stress. The specific aims are: 1) using animal models to examine a role of the MDM2/MDMX complex in p53 regulation; 2) characterize the MDM2/MDMX complex-mediated p53 ubiquitination; 3) investigate cellular mechanisms that regulate the MDM2/MDMX complex. With the knock-in mice being successfully generated, we are very favorably positioned to carry out the proposed studies. The findings obtained from the proposed work are expected not only to shed light on the non-redundant function of MDM2 and MDMX, but also to provide a novel mechanism of p53 regulation.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.21037/tcr.2016.12.18
发表时间:
2016-12
期刊:
Translational cancer research
影响因子:
0.9
作者:
[de Polo A, Vivekanandan V, Little JB, Yuan ZM]
通讯作者:
Yuan ZM
PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis.
PRR14是促进肺癌发生的PI3K途径的新型激活剂。
DOI:
10.1038/onc.2016.93
发表时间:
2016-10-20
期刊:
Oncogene
影响因子:
8
作者:
[Yang M, Lewinska M, Fan X, Zhu J, Yuan ZM]
通讯作者:
Yuan ZM
DOI:
10.1038/onc.2013.81
发表时间:
2014-03-13
期刊:
Oncogene
影响因子:
8
作者:
[]
通讯作者:
DOI:
10.1038/onc.2015.371
发表时间:
2016-06-09
期刊:
Oncogene
影响因子:
8
作者:
[Liu XS, Liu Z, Gerarduzzi C, Choi DE, Ganapathy S, Pandolfi PP, Yuan ZM]
通讯作者:
Yuan ZM
DOI:
10.1038/cddis.2015.103
发表时间:
2015-04-23
期刊:
Cell death & disease
影响因子:
9
作者:
[Yang M, Yuan ZM]
通讯作者:
Yuan ZM
共 9 条
Target MDM2/MDMX for reducing normal tissue toxicity induced by chemotherapy
-
批准号:9814796
-
项目类别:
-
资助金额:$36.49万
-
财政年份:2019
-
负责人:ZHI-MIN YUAN
-
依托单位:
Target MDM2/MDMX for reducing normal tissue toxicity induced by chemotherapy
-
批准号:10200710
-
项目类别:
-
资助金额:$36.49万
-
财政年份:2019
-
负责人:ZHI-MIN YUAN
-
依托单位:
A p53/NFkB-mediated metabolic mechanism for chemotherapy protection
-
批准号:9247711
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2014
-
负责人:ZHI-MIN YUAN
-
依托单位:
A p53/NFkB-mediated metabolic mechanism for chemotherapy protection
-
批准号:8707715
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2014
-
负责人:ZHI-MIN YUAN
-
依托单位:
Modulation of p53 function by tyrosine kinase networks
-
批准号:8704895
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2012
-
负责人:ZHI-MIN YUAN
-
依托单位:
Modulation of p53 function by tyrosine kinase networks
-
批准号:8541797
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2012
-
负责人:ZHI-MIN YUAN
-
依托单位:
Modulation of p53 function by tyrosine kinase networks
-
批准号:9114862
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2012
-
负责人:ZHI-MIN YUAN
-
依托单位:
Modulation of p53 function by tyrosine kinase networks
-
批准号:8896554
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2012
-
负责人:ZHI-MIN YUAN
-
依托单位:
Modulation of p53 function by tyrosine kinase networks
-
批准号:8396043
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2012
-
负责人:ZHI-MIN YUAN
-
依托单位:
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesis
-
批准号:7687985
-
项目类别:
-
资助金额:$30.81万
-
财政年份:2008
-
负责人:ZHI-MIN YUAN
-
依托单位:
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesis
-
批准号:7524357
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2008
-
负责人:ZHI-MIN YUAN
-
依托单位:
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesis
-
批准号:8111200
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2008
-
负责人:ZHI-MIN YUAN
-
依托单位:
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesis
-
批准号:8305136
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2008
-
负责人:ZHI-MIN YUAN
-
依托单位:
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesis
-
批准号:7893869
-
项目类别:
-
资助金额:$30.81万
-
财政年份:2008
-
负责人:ZHI-MIN YUAN
-
依托单位:
MOLECULAR BASIS OF P53 INDUCTION TO DNA DAMAGE
-
批准号:6286907
-
项目类别:
-
资助金额:$27.65万
-
财政年份:2001
-
负责人:ZHI-MIN YUAN
-
依托单位:
MOLECULAR BASIS OF P53 INDUCTION TO DNA DAMAGE
-
批准号:6514435
-
项目类别:
-
资助金额:$23.53万
-
财政年份:2001
-
负责人:ZHI-MIN YUAN
-
依托单位:
MOLECULAR BASIS OF P53 INDUCTION TO DNA DAMAGE
-
批准号:6633668
-
项目类别:
-
资助金额:$23.53万
-
财政年份:2001
-
负责人:ZHI-MIN YUAN
-
依托单位:
Molecular Basis of p53-Induction to DNA Damage
-
批准号:7425405
-
项目类别:
-
资助金额:$7.62万
-
财政年份:2001
-
负责人:ZHI-MIN YUAN
-
依托单位:
MDM2 and MDMX function together as the p53 E3 ligase
-
批准号:8108134
-
项目类别:
-
资助金额:$24.55万
-
财政年份:2001
-
负责人:ZHI-MIN YUAN
-
依托单位:
Molecular Basis of p53-Induction to DNA Damage
-
批准号:7687150
-
项目类别:
-
资助金额:$17.58万
-
财政年份:2001
-
负责人:ZHI-MIN YUAN
-
依托单位:
海外基金